Addus HomeCare (ADUS) delivered earnings and revenue surprises of +2.81% and -0.16%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Jack Henry & Assoc (JKHY-Q) from The Globe and Mail including charting and trades.
Detailed price information for Genpact Ltd (G-N) from The Globe and Mail including charting and trades.
When examining a long-term compounder, astute market participants look past quarterly headlines to evaluate core operational drivers, margin stability, and pricing power. Addus HomeCare (NASDAQ:ADUS) embodies many classic characteristics of a durable portfolio holding: a sticky, non-franchise personal care delivery model, consistent organic growth, and a disciplined approach to capital allocation across fragmented regional markets. […]
Addus HomeCare (ADUS) heads into its 2026 Jefferies Healthcare Services and Technology Conference appearance with fresh attention on its AccentCare personal care acquisition and the stock’s recent sector driven move. After a strong run that produced a 23.45% 90 day share price return and lifted year to date share price gains to 8.73%, Addus HomeCare has seen momentum cool slightly in the last week as investors weigh the AccentCare deal, evolving Medicaid headlines, and the stock’s longer term...
Addus HomeCare (ADUS) has an average rating of overweight and mean price target of $133.69, accordin
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Addus HomeCare' (ADUS) $275 million acquisition of AccentCare's personal care division will likely s
Addus HomeCare (ADUS) said Monday that it has agreed to acquire AccentCare's personal care division
Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential
FRISCO, Texas, September 14, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced a definitive agreement to acquire the personal care division of AccentCare for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The transaction relates only to AccentCare’s personal care operations outside of New York and does not relate to its hospice and home health operations. The acquired operations serve an
(Updated to include prior price target in headline.) Addus HomeCare (ADUS) has an average rating
Detailed price information for Western Digital Corp (WDC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Allison Transmission Holdings (ALSN-N) from The Globe and Mail including charting and trades.
FRISCO, Texas, September 08, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee.
Detailed price information for Ellington Financial Llc (EFC-N) from The Globe and Mail including charting and trades.
Addus HomeCare Q2 results and what they mean for the stock Addus HomeCare (ADUS) drew attention after reporting Q2 2026 results that showed revenue in line with expectations alongside an earnings per share beat. For investors, that mix raises fresh questions about how the stock reflects its fundamentals. The share price of Addus HomeCare has eased slightly in the short term, with the 1-day, 7-day and 30-day share price returns all down modestly, even after a strong 90-day share price return...
Addus HomeCare stock has delivered a 34.6% gain over the past three years, while a fresh intrinsic value estimate suggests the current price may still sit below what its future cash flows imply. The market price near US$118 puts investors between a strong historical return and an analytical view that points to possible undervaluation. A 34.6% share price gain over three years shows that Addus HomeCare has already rewarded patient investors, so the question is how much of the long term...
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.
Investors need to pay close attention to ADUS stock based on the movements in the options market lately.
This is the newest page. Registered accounts read further back.